Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $392.5 million.

  • Pediatrix Medical's Total Current Liabilities rose 521.79% to $392.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $392.5 million, marking a year-over-year increase of 521.79%. This contributed to the annual value of $434.1 million for FY2024, which is 1161.19% up from last year.
  • As of Q3 2025, Pediatrix Medical's Total Current Liabilities stood at $392.5 million, which was up 521.79% from $341.0 million recorded in Q2 2025.
  • Pediatrix Medical's Total Current Liabilities' 5-year high stood at $434.1 million during Q4 2024, with a 5-year trough of $247.3 million in Q1 2024.
  • Over the past 5 years, Pediatrix Medical's median Total Current Liabilities value was $350.4 million (recorded in 2023), while the average stood at $347.1 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first crashed by 1859.27% in 2021, then skyrocketed by 1161.19% in 2024.
  • Pediatrix Medical's Total Current Liabilities (Quarter) stood at $427.4 million in 2021, then dropped by 0.09% to $427.0 million in 2022, then dropped by 8.91% to $388.9 million in 2023, then grew by 11.61% to $434.1 million in 2024, then dropped by 9.57% to $392.5 million in 2025.
  • Its last three reported values are $392.5 million in Q3 2025, $341.0 million for Q2 2025, and $271.1 million during Q1 2025.